Trial Profile
Research Study to Evaluate LOTRONEX in Severe IBS-D: Analysis of Current Clinical Practice Environment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2013
Price :
$35
*
At a glance
- Drugs Alosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Acronyms RELIANCE
- Sponsors Prometheus Laboratories
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record